Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBC

(Updated - November 5, 2015 2:23 PM EST)

Bill Ackman supports Valeant Pharma (NYSE: VRX) CEO Mike Pearson, according to a letter seen by CNBC.

In a letter to Mr. Person, Ackman said, "In light of recent press reports, I though it would be helpful for me to communicate my thoughts on your leadership of Valeant. We share the board's confidence in you and your leadership."

You May Also Be Interested In

• Hunterbrook Capital is short bonds issued by Sammons Financial Group and short Guggenheim Strategic Opportunities Fund
• Lunai Bioworks expands naked short selling lawsuit to add six broker-dealers
• Morningstar Q&A: AI Pricing, PitchBook Growth and Private Markets